Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
Clinical trial NCT04756037 · COMPLETED
Trial details
- NCT number
- NCT04756037
- Sponsor
- Sumitomo Pharma Switzerland GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-18
- Primary completion
- 2025-02-25
- Enrollment
- 1164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.